WINDWARD BIO GROUP AG (WWB) Insider Trading -- Recent Executive & Director Transactions
7 insiders reported 24 Form 4 transactions for WINDWARD BIO GROUP AG (WWB) over the past 18 months (most recent 2026-11-18). Recent activity: OrbiMed Capital GP IX LLC (Director) Buy 3.6M shares, Bonita David P (Director) Buy 1.2M shares, OrbiMed Capital GP IX LLC (Director) Buy 1.2M shares, ORBIMED ADVISORS LLC (Director) Buy 3.6M shares, Stampacchia Otello (Director) Buy 875,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-18 | OrbiMed Capital GP IX LLC | Director | Buy | 3.6M | $0 |
| 2026-11-18 | Bonita David P | Director | Buy | 1.2M | $20.0M |
| 2026-11-18 | OrbiMed Capital GP IX LLC | Director | Buy | 1.2M | $20.0M |
| 2026-11-18 | ORBIMED ADVISORS LLC | Director | Buy | 3.6M | $0 |
| 2026-11-18 | Stampacchia Otello | Director | Buy | 875,000 | $14.9M |
| 2026-11-18 | Bonita David P | Director | Buy | 3.6M | $0 |
| 2026-11-18 | ORBIMED ADVISORS LLC | Director | Buy | 1.2M | $20.0M |
| 2026-11-18 | ORBIMED ADVISORS LLC | Director | Buy | 1.6M | $0 |
| 2026-11-18 | Stampacchia Otello | Director | Buy | 1.3M | $0 |
| 2026-11-18 | Bonita David P | Director | Buy | 1.6M | $0 |
| 2026-11-18 | OrbiMed Capital GP IX LLC | Director | Buy | 1.6M | $0 |
| 2026-11-18 | ORBIMED ADVISORS LLC | Director | Buy | 216,668 | $4,333 |
| 2026-11-18 | Stampacchia Otello | Director | Buy | 1.3M | $0 |
| 2026-11-18 | Bonita David P | Director | Buy | 216,668 | $4,333 |
| 2026-11-18 | OrbiMed Capital GP IX LLC | Director | Buy | 216,668 | $4,333 |
| 2026-11-18 | ORBIMED ADVISORS LLC | Director | Sell | 232 | $3,944 |
| 2026-11-18 | Stampacchia Otello | Director | Buy | 531,632 | $0 |
| 2026-11-18 | Bonita David P | Director | Sell | 232 | $3,944 |
| 2026-11-18 | OrbiMed Capital GP IX LLC | Director | Sell | 232 | $3,944 |
| 2026-11-18 | Stampacchia Otello | Director | Buy | 531,634 | $0 |
| 2026-11-18 | Stampacchia Otello | Director | Buy | 875,000 | $14.9M |
| 2026-11-16 | Harris Kevin Andrew | Chief Operating Officer | Buy | 33,206 | $0 |
| 2026-11-16 | Applebaum Scott | Chief Legal & Corp Dev Officer | Buy | 33,206 | $0 |
| 2026-11-16 | Kapadia Sandip | Director | Buy | 100,000 | $0 |
Source: SEC Form 4 filings · as of 2026-11-18